Clinical Trials Sponsored by Xue Yingwei

Total 253 results

Xue Yingwei

Active, not recruiting

A Clinical Study for Comparison of the Effects Between Gasless Laparoscopy and Conventional Laparoscopy for Distal Gastric Cancer

Gastrectomy | Laparoscopy

China
Xingwei Xu

Completed

Pectin Start Early Enteral Nutritional Support in Critically Ill Patients

Critical Illness | Nutrition Disorders
Xue Yingwei

Completed

A Clinical Study of the Effects of Modified BII+Braun on Quality of Life After for Distal Gastric Cancer

Quality of Life

China
Xiali Xue

Not yet recruiting

Effect of Extracorporeal Shock Wave Combined With Autologous Platelet-rich Plasma Injection on Rotator Cuff Calcific Tendinitis

Rotator Cuff Tendinitis | Rotator Cuff Tendinosis
Xue Xia

Completed

Low-frequency Electrical Stimulation of Acupuncture Points

Stroke Sequelae

China
Yan Xue

Active, not recruiting

Efficacy and Safety of Inetetamab Plus Pyrotiniband and Capecitabine in HER2-positive Metastatic Breast Cancer Patients With or Without Brain Metastasis

Breast Cancer

China
Qingwei Jiang

Recruiting

Cold or Hot Snare Endoscopic Mucosal Resection for 10-19mm Non-pedunculated Colorectal Polyps

Colorectal Polyp

China
Shanghai YingLi Pharmaceutical Co. Ltd.
Yingli Pharma US, Inc

Recruiting

YL-13027 in Patients With Advanced Solid Tumors

Solid Tumor

United States
Shanghai YingLi Pharmaceutical Co. Ltd.
Yingli Pharma US, Inc

Recruiting

A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation

Advanced Solid Tumor

United States
Yan Xue

Recruiting

Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients

Breast Cancer

China
Xue-chun Lu

Recruiting

Combination Regimen With Sodium Valproate for Severe Hemophilia: a Single-arm, Phase 1, Pilot Trial.

Hemophilia

China
Yang Xinwei

Active, not recruiting

Clinical Efficacy and Safety of Perampanel Monotherapy in the Treatment of Children With Focal Epilepsy

Focal Epilepsy

China
Sue Ryder Care

Unknown

Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients? Formal Study

Nausea | Vomiting

United Kingdom
Cue Biopharma

Recruiting

A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer

United States
Que Oncology

Completed

Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen

Vasomotor Symptoms (VMS)
Shanghai YingLi Pharmaceutical Co. Ltd.

Not yet recruiting

A National Multicenter, Real-world Study of Linperlisib in the Treatment of Lymphoma

Indolent B-cell Lymphoma
Shanghai YingLi Pharmaceutical Co. Ltd.

Not yet recruiting

A Study of HY-0102 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Recruiting

A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Not yet recruiting

A Study of Linperlisib Combination With Camrelizumab in Patients With Solid Tumor

Advanced Solid Tumor
Shanghai YingLi Pharmaceutical Co. Ltd.

Enrolling by invitation

Phase I Clinical Study of YL-15293 in Patients With Advanced Solid Tumor With KRAS Mutation

Advanced Solid Tumor

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Unknown

A Phase Ib Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

Relapsed or Refractory Peripheral T-Cell Lymphoma

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Unknown

A Phase I Study of YY-20394 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Recruiting

A Study of YL-17231 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Recruiting

A Phase II Study of Linperlisib (YY-20394) in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma

Peripheral T/NK Cell Lymphoma (R/R PTCL)

United States
Shanghai YingLi Pharmaceutical Co. Ltd.

Not yet recruiting

A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Thymic Cancer

Effectiveness，Safety，Thymic Cancer
Shanghai YingLi Pharmaceutical Co. Ltd.

Unknown

YY-20394 、GEMOX Treatment Diffuse Large B-cell Lymphoma Single Arm, Open, Multicentrized Phase 1b/2 Clinical Trial

Diffuse Large B Cell Lymphoma
Shanghai YingLi Pharmaceutical Co. Ltd.

Unknown

A Study of YY-20394 in Participants With Relapsed/Refractory Follicular Non-Hodgkin's Lymphoma

Lymphoma, Follicular

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Unknown

A Phase I Study of YY-20394 in Patients With B Cell Hematologic Malignancies

B-cell Chronic Lymphocytic Leukemia | B-cell Lymphoma Recurrent

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Not yet recruiting

Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS

Advanced Solid Tumors

United States
Shanghai YingLi Pharmaceutical Co. Ltd.

Not yet recruiting

A Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma

PTCL
Shanghai YingLi Pharmaceutical Co. Ltd.

Recruiting

First in Human Dose Escalation Study of YL-13027 in Subjects With Advanced Stage Solid Tumors

Advanced Solid Tumors

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Unknown

A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular Lymphoma

Follicular Lymphoma
Shanghai YingLi Pharmaceutical Co. Ltd.

Unknown

A Phase Ib Study of YY-20394 in Participants With B-cell Hematologic Malignancies

Mantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma
Xue Xiaoying

Completed

Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial

Glioma | Radiotherapy, Intensity-Modulated | Maximum Tolerated Dose
Qing XIe

Recruiting

A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients

Chronic Hepatitis B | Intermediate to High Risk of HCC

China
Que Oncology
Syneos Health

Completed

Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor

Vasomotor Symptoms (VMS)

United States, New Zealand, Australia
Jiao Mingfei

Unknown

Intravitreal Conbercept for Idiopathic Choroidal Neovascularization

Idiopathic Choroidal Neovascularization

China
Huaping Xie

Recruiting

Clinical Study of Resistant Starch in Improving Constipation

Constipation

China
Qiuyou Xie

Recruiting

Effects of Individualized rTMS in DOC Patients

Transcranial Magnetic Stimulation | Disorder of Consciousness

China
Xiang Xie
Xinjiang Medical University

Not yet recruiting

Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer

Cancer | Atherosclerotic Cardiovascular Disease | ASCVD | Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor
Jianfeng Xie

Recruiting

The Effect and Mechanism of lncRNA NBR2 Regulating Endothelial Pyroptosis by Targeting GSDMD in Sepsis

Sepsis

China
Xiang Xie

Completed

Cohort Study of Chronic Heart Failure

Analyze Etiology, Comorbidities, Clinical Characteristics
xie congying

Completed

Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma

Gastric Cancer

China
Sue O'Dorisio
University of Iowa

Completed

Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors

Neuroendocrine Tumors | Medulloblastoma | Neuroblastoma | Carcinoid Tumors

United States
Jianfeng Xie

Completed

ARDS Prediction Score in Critically Ill Patients in China

Septic Shock | ARDS

China
Xing Xie, MD

Unknown

Prevaccination Study of Cervical Human Papillomavirus Types in Yangtze River Delta Area, China

Cervical Cancer | Cervical Intraepithelial Neoplasia | Human Papilloma Virus

China
Peking University
Yingkai Saiwei（Beijing）Biotechnology Co., Ltd

Not yet recruiting

Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Solid Tumor

Advanced Solid Tumor

China
Qing XIe

Recruiting

Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）

Chronic Hepatitis b

China
Huaping Xie

Not yet recruiting

Influence of Ear Vagus Nerve Stimulator on Patients With IBS

Irritable Bowel Syndrome
Qiuyou Xie

Recruiting

Personal Music for Disorders of Consciousness

Disorder of Consciousness

China

3

Subscribe